161 related articles for article (PubMed ID: 11239866)
1. Additive efficacy of unoprostone isopropyl 0.12% (rescula) to latanoprost 0.005%.
Stewart WC; Sharpe ED; Stewart JA; Holmes KT; Latham KE
Am J Ophthalmol; 2001 Mar; 131(3):339-44. PubMed ID: 11239866
[TBL] [Abstract][Full Text] [Related]
2. A randomized double-masked crossover study comparing latanoprost 0.005% with unoprostone 0.12% in patients with primary open-angle glaucoma and ocular hypertension.
Aung T; Chew PT; Yip CC; Chan YH; See JL; Khng CG; Hoh ST; Ng LH; Lee HM
Am J Ophthalmol; 2001 May; 131(5):636-42. PubMed ID: 11336940
[TBL] [Abstract][Full Text] [Related]
3. Additive efficacy of unoprostone isopropyl 0.12% (rescula) to latanoprost 0.005%.
Alward WL
Am J Ophthalmol; 2001 Sep; 132(3):449-51. PubMed ID: 11554384
[No Abstract] [Full Text] [Related]
4. Additive efficacy of unoprostone isopropyl 0.12% (rescula) to latanoprost 0.005%.
Eisenberg DL
Am J Ophthalmol; 2001 Sep; 132(3):448-9. PubMed ID: 11554383
[No Abstract] [Full Text] [Related]
5. A comparative clinical study of latanoprost and isopropyl unoprostone in Japanese patients with primary open-angle glaucoma and ocular hypertension.
Tsukamoto H; Mishima HK; Kitazawa Y; Araie M; Abe H; Negi A;
J Glaucoma; 2002 Dec; 11(6):497-501. PubMed ID: 12483094
[TBL] [Abstract][Full Text] [Related]
6. Comparative effects of latanoprost (Xalatan) and unoprostone (Rescula) in patients with open-angle glaucoma and suspected glaucoma.
Sponsel WE; Paris G; Trigo Y; Pena M
Am J Ophthalmol; 2002 Oct; 134(4):552-9. PubMed ID: 12383812
[TBL] [Abstract][Full Text] [Related]
7. A double-masked, randomized clinical trial comparing latanoprost with unoprostone in patients with open-angle glaucoma or ocular hypertension.
Susanna R; Giampani J; Borges AS; Vessani RM; Jordao ML
Ophthalmology; 2001 Feb; 108(2):259-63. PubMed ID: 11158796
[TBL] [Abstract][Full Text] [Related]
8. Randomized clinical trial of latanoprost and unoprostone in patients with elevated intraocular pressure.
Jampel HD; Bacharach J; Sheu WP; Wohl LG; Solish AM; Christie W;
Am J Ophthalmol; 2002 Dec; 134(6):863-71. PubMed ID: 12470755
[TBL] [Abstract][Full Text] [Related]
9. Additive effect of unoprostone and latanoprost in patients with elevated intraocular pressure.
Aung T; Chew PT; Oen FT; Chan YH; Thean LH; Yip L; Lim BA; Soh J; Seah SK
Br J Ophthalmol; 2002 Jan; 86(1):75-9. PubMed ID: 11801508
[TBL] [Abstract][Full Text] [Related]
10. A comparison of intraocular pressure-lowering effect of prostaglandin F2 -alpha analogues, latanoprost, and unoprostone isopropyl.
Kobayashi H; Kobayashi K; Okinami S
J Glaucoma; 2001 Dec; 10(6):487-92. PubMed ID: 11740220
[TBL] [Abstract][Full Text] [Related]
11. Effects of latanoprost and unoprostone when used alone or in combination for open-angle glaucoma.
Saito M; Takano R; Shirato S
Am J Ophthalmol; 2001 Oct; 132(4):485-9. PubMed ID: 11589867
[TBL] [Abstract][Full Text] [Related]
12. Substituting latanoprost (Xalatan) for isopropyl unoprostone (Rescula) in monotherapy and combination therapy.
Tsukamoto H; Yokoyama T; Okada K; Okada M; Mochizuki H; Mishima HK
Acta Ophthalmol Scand; 2000 Oct; 78(5):604-5. PubMed ID: 11037926
[No Abstract] [Full Text] [Related]
13. A double-masked randomized comparison of the efficacy and safety of unoprostone with timolol and betaxolol in patients with primary open-angle glaucoma including pseudoexfoliation glaucoma or ocular hypertension. 6 month data.
Nordmann JP; Mertz B; Yannoulis NC; Schwenninger C; Kapik B; Shams N;
Am J Ophthalmol; 2002 Jan; 133(1):1-10. PubMed ID: 11755834
[TBL] [Abstract][Full Text] [Related]
14. The efficacy and safety of latanoprost 0.005% once daily versus brimonidine 0.2% twice daily in open-angle glaucoma or ocular hypertension.
Stewart WC; Day DG; Stewart JA; Schuhr J; Latham KE
Am J Ophthalmol; 2001 May; 131(5):631-5. PubMed ID: 11336939
[TBL] [Abstract][Full Text] [Related]
15. Intraocular pressure fluctuations in response to the water-drinking provocative test in patients using latanoprost versus unoprostone.
Susanna R; Medeiros FA; Vessani RM; Giampani J; Borges AS; Jordão ML
J Ocul Pharmacol Ther; 2004 Oct; 20(5):401-10. PubMed ID: 15650515
[TBL] [Abstract][Full Text] [Related]
16. Timolol 0.5%/dorzolamide 2% fixed combination vs timolol maleate 0.5% and unoprostone 0.15% given twice daily to patients with primary open-angle glaucoma or ocular hypertension.
Day DG; Schacknow PN; Wand M; Sharpe ED; Stewart JA; Leech J; Stewart WC
Am J Ophthalmol; 2003 Feb; 135(2):138-43. PubMed ID: 12566015
[TBL] [Abstract][Full Text] [Related]
17. A comparative study of latanoprost (Xalatan) and isopropyl unoprostone (Rescula) in normal and glaucomatous monkey eyes.
Serle JB; Podos SM; Kitazawa Y; Wang RF
Jpn J Ophthalmol; 1998; 42(2):95-100. PubMed ID: 9587840
[TBL] [Abstract][Full Text] [Related]
18. A preliminary risk-benefit assessment of latanoprost and unoprostone in open-angle glaucoma and ocular hypertension.
Eisenberg DL; Camras CB
Drug Saf; 1999 Jun; 20(6):505-14. PubMed ID: 10392667
[TBL] [Abstract][Full Text] [Related]
19. The effects of unoprostone isopropyl 0.12% and timolol maleate 0.5% on diurnal intraocular pressure.
Stewart WC; Stewart JA; Kapik BM
J Glaucoma; 1998 Dec; 7(6):388-94. PubMed ID: 9871860
[TBL] [Abstract][Full Text] [Related]
20. Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension.
Netland PA; Landry T; Sullivan EK; Andrew R; Silver L; Weiner A; Mallick S; Dickerson J; Bergamini MV; Robertson SM; Davis AA;
Am J Ophthalmol; 2001 Oct; 132(4):472-84. PubMed ID: 11589866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
